Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8696.10x is 375% below its 1-year average of -1829.29x, near the low end of its 1-year range (-8696.10x–-2.22x).
As of the fiscal period ended Thursday, March 31, 2022. 239.86% below its 12-month average of -2558.71x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2022 (2022-03-31): -8696.10x.
INTEREST COVERAGE RATIO
-8696.10x
INTEREST COVERAGE RATIO AVG TTM
-2558.71x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-239.86%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-136309.34%
vs the sector median at left
MiNK Therapeutics, Inc.
Market Cap
$58.29M
Interest Coverage Ratio
-8696.10x
TTM Avg
-2558.71x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.43M
Interest Coverage Ratio
-3392.06x
TTM Avg
18.65x
3Y Avg
15.79x
5Y Avg
19.13x
Market Cap
$58.44M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.06M
Interest Coverage Ratio
-31.98x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$57.01M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.29M | -8696.10x | -2558.71x | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | -3392.06x | 18.65x | 15.79x | 19.13x |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | -5.91x | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -31.98x | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Talphera, Inc. (TLPH)vs › | $57.61M | N/A | N/A | N/A | N/A |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | N/A | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | N/A | N/A | N/A |
Interest Coverage
-8696.1x
Debt/Equity
N/A
Current Ratio
1.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-03-31 | -8696.10x |
| 2021-12-31 | -4080.80x |
| 2021-09-30 | -4.71x |
| 2021-06-30 | -6.97x |
| 2021-03-31 | -4.97x |
| 2020-12-31 | -2.22x |
| 2020-09-30 | -9.27x |
